Gufic Biosciences Limited (NSE:GUFICBIO) Q2 FY23 Earnings Concall dated Nov.13, 2022 Corporate Participants: Ami Naresh Shah -- Company Secretary and Compliance Officer Avik Das -- Investor
Gufic Biosciences Limited
-(GUFICBIO)
XNSE:GUFICBIO, XBOM:GUFICBIO
Gufic Biosciences Limited Q1 FY23 Earnings Conference Call Insights
https://youtu.be/l4VNZKKcWGw Key highlights from Gufic Biosciences Limited (GUFICBIO) Q1 FY23 Earnings Concall Q&A Highlights: Girish Gulati asked about pancreatic cancer update and
Gufic Biosciences Limited Q3 FY22 Earnings Conference Call Insights
https://youtu.be/f3tlyxhD91U Key highlights from Gufic Biosciences Limited (GUFICBIO) Q3 FY22 Earnings Concall Management Update: In CDMO, GUFICBIO said it’s looking at a